BusinessEditas Medicine to Host Conference Call Discussing Third Quarter 2017 Corporate Update and ResultsBy Nasdaq OMXNov 3, 2017, 12:01 PM UTC
BusinessEditas Medicine to Present Data on CRISPR/Cas9-mediated Gene Editing in Hematopoietic Stem/Progenitor Cells at ESGCT-ISSCR 2016By Nasdaq OMXOct 17, 2016, 11:30 AM UTC
